Literature DB >> 33866374

The School Career of Children With Hearing Loss in Different Primary Educational Settings-A Large Longitudinal Nationwide Study.

Tirza F K van der Straaten1, Jeroen J Briaire1, Evelien Dirks2, Wim Soede1, Carolien Rieffe3,4, Johan H M Frijns1,5.   

Abstract

Children with hearing loss (HL) are at risk for a lower educational achievement. This longitudinal study compared the school career of a nationwide Dutch cohort with and without HL based on descriptive data of the governmental authority Statistics Netherlands. From 2008 to 2018, 3,367,129 children, of whom 1,193 used cochlear implants (CIs) and 8,874 used hearing aids (HAs), were attending primary and/or secondary education. Sixty-one percent of children with HL attended mainstream and 31% special primary education. Compared to mainstreamed pupils without HL, mainstreamed pupils with HL achieved lower levels for language and mathematics in primary education but eventually attended comparable types of secondary education. Children with HL attending special primary education attained lower types of secondary education compared to mainstreamed peers with and without HL. These findings suggest that future educational (and as a result professional) attainment of a child with HL depends on the type of primary educational setting.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Year:  2021        PMID: 33866374     DOI: 10.1093/deafed/enab008

Source DB:  PubMed          Journal:  J Deaf Stud Deaf Educ        ISSN: 1081-4159


  2 in total

1.  Mathematics anxiety in deaf, hard of hearing, and hearing college students.

Authors:  Akriti Mishra; Kristin Walker; Briana Oshiro; Clifton Langdon; Marie Coppola
Journal:  Ann N Y Acad Sci       Date:  2022-04-01       Impact factor: 6.499

2.  Cost-benefit Analysis of Cochlear Implants: A Societal Perspective.

Authors:  Olaf M Neve; Jenneke A Boerman; Wilbert B van den Hout; Jeroen J Briaire; Peter P G van Benthem; Johan H M Frijns
Journal:  Ear Hear       Date:  2021 Sep/Oct       Impact factor: 3.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.